NDC 17856-1544-2 - Potassium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1544
- Requested NDC
- 17856-1544-2
- Package NDCs from labels
- 17856-1544-2, 17856-1544-1
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2024-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Potassium Chloride - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2024-06-05 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1544-1 | Potassium Chloride | 72 in 1 BOX, UNIT-DOSE | SOLUTION | 72 | 3 | |
| 17856-1544-2 | Potassium Chloride | 15 mL in 1 CUP | SOLUTION | 15 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1544 | POTASSIUM CHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORP.] | 3 | Legacy NDC, 2 package rows | 20240606_cc912caf-f4d9-4c08-ba9f-45c5e8ed8060.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Elimitone | BELLIS PERENNIS, ECHINACEA (ANGUSTIFOLIA), TRIFOLIUM PRATENSE, PHYTOLACCA DECANDRA, ARNICA MONTANA, ANAS BARBARIAE, HEPATIS ET CORDIS EXTRACTUM, CALCAREA IODATA, KALI MURIATICUM, NITRICUM ACIDUM, PHOSPHORICUM ACIDUM, SULPHUR IODATUM | Energique, Inc. | bc6352e0-6851-4971-948b-b18da7c1c8b6 | 2024-10-24 | Warnings | 660YQ98I10 |
| Bliss GVS Children | GLYCERIN | Bliss GVS Pharma Limited | 03237ed2-265f-4acd-b504-d82b9263287c | 2024-10-17 | Warnings | PDC6A3C0OX |
| LACTATED RINGERS | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Becton Dickinson and Company | bb2ad9cd-5d9a-4337-be61-0842d738c79e | 2024-10-16 | Warnings, Adverse reactions | 660YQ98I10 |
| Elliotts B | SODIUM CATION, SODIUM BICARBONATE, ANHYDROUS DEXTROSE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM PHOSPHATE | Lukare Medical, LLC | 08036dbd-55b3-47b9-9890-000f253544f3 | 2024-10-16 | Warnings, Adverse reactions | 660YQ98I10 |
| LACTATED RINGERS | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Fresenius Kabi USA, LLC | 8fce1477-991f-4b43-bf05-a80bad897262 | 2024-10-16 | Warnings, Adverse reactions | 660YQ98I10 |
| EyS Eye Wash | WATER | Eyes-Plus LLC | 1443f6bf-3a77-4a19-8585-0ec58efe042f | 2024-10-15 | Warnings | 059QF0KO0R |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Meijer Distribution Inc | fb170371-2e5d-43ca-a259-538a973ee3b8 | 2024-10-15 | Warnings | PDC6A3C0OX |
| topcare hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Topco Associates LLC | 5e13da07-48cf-40bc-bb11-fd891886cbea | 2024-10-14 | Warnings | PDC6A3C0OX |
| Eye Wash | WATER SOLUTION | Kroger Company | 354402ad-581d-47e7-9fd3-933bef281ff4 | 2024-10-11 | Warnings | 059QF0KO0R |
| Eye Wash | WATER | Hubei Changjian Medical Products Co., Ltd. | d57e1c5b-1edc-4a94-88bc-f9ecf347b7ea | 2024-10-11 | Warnings | 059QF0KO0R |
| Bliss GVS | GLYCERIN | Bliss GVS Pharma Limited | 1a3982a1-9ce9-4a1a-ba73-ebe2d8647109 | 2024-10-10 | Warnings | PDC6A3C0OX |
| teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 86b3a329-c83f-4977-92f5-0e9dfe1872d7 | 2024-10-10 | Warnings | XF417D3PSL |
| Bio Co-Enzyme Phase | CARDUUS MARIANUS, ASCORBICUM ACIDUM, CYSTEINUM, NATRUM OXALACETICUM, NICOTINAMIDUM, PULSATILLA (PRATENSIS), PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, THIAMINUM HYDROCHLORICUM, ALPHA-KETOGLUTARICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CERIUM OXALICUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MAGNESIUM OROTICUM DIHYDRICUM, MALICUM ACIDUM, NADIDUM, NATRUM PYRUVICUM, PANTOTHENIC ACID, SUCCINICUM ACIDUM, ADRENALINUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, HEPAR SULPHURIS CALCAREUM, SULPHUR, ACONITICUM ACIDUM, CIS-, | Deseret Biologicals, Inc. | afad858e-064f-454d-be78-da1501ffe853 | 2024-10-04 | Warnings | XF417D3PSL |
| Hydration Complex | BOLDO, CARDUUS BENEDICTUS, CARDUUS MARIANUS, CHELIDONIUM MAJUS, COFFEA TOSTA, EQUISETUM ARVENSE, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, HYPERICUM PERFORATUM, GINKGO BILOBA, KALI MURIATICUM, KALI PHOSPHORICUM, KALI SULPHURICUM, GERMANIUM SESQUIOXIDE, SILICEA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA | Deseret Biologicals, Inc. | 891265ff-2651-4d84-a77b-331e3eb7e3ec | 2024-10-04 | Warnings | 660YQ98I10 |
| TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 39f2e11c-5a31-469f-b725-d096c1674421 | 2024-10-03 | Warnings | XF417D3PSL |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 473369cb-3a9b-437c-b08e-8fb38034c507 | 2024-10-03 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Proficient Rx LP | f191b15c-7959-4aa6-a2ef-617cde77c918 | 2024-10-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE | Somerset Therapeutics, LLC | 32809eae-1c3f-96fc-e063-6394a90aeaad | 2024-09-30 | Warnings, Adverse reactions | 660YQ98I10 |
| SODIUM PHENYLACETATE AND SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Zydus Pharmaceuticals USA Inc. | 204e84a7-5440-4537-9e40-06eb56c415e9 | 2024-09-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Sodium Phenylacetate and sodium benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Navinta LLC | fbc7bfe3-6faa-45a3-befb-9ad7963c0571 | 2024-09-30 | Warnings, Adverse reactions | OJ245FE5EU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.